Lv4
490 积分 2022-12-21 加入
Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986)
5小时前
已完结
Mediators of Chronic Obstructive Pulmonary Disease
12天前
已完结
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study
29天前
已完结
Humanized BAFF transgenic mice develop autoimmune manifestations
1个月前
已完结
Humanized BAFF transgenic mice develop autoimmune manifestations
1个月前
已完结
Effects of Gastric Acid Suppression, Cytochrome P4503A Inhibition and Induction, and Food on the Pharmacokinetics of Tinlarebant in Healthy Adults
2个月前
已完结
Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development
2个月前
已完结
In vitro cytokine release assays for commercially available biologics for predicting cytokine storm in human patients (P6321)
2个月前
已关闭
The Discovery of N-(1-Methyl-5-(trifluoromethyl)-1H-pyrazol-3-yl)-5-((6- ((methylamino)methyl)pyrimidin-4-yl)oxy)-1H-indole-1-carboxamide (Acrizanib), a VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration
3个月前
已完结
α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1
3个月前
已完结
皖公网安备34019202002308
